ClinicalTrials.Veeva

Menu

Camelia Sinensis for Basal Metabolism and Body Composition

A

Azienda di Servizi alla Persona di Pavia

Status

Unknown

Conditions

Postmenopausal Disorder

Treatments

Combination Product: Placebo
Dietary Supplement: Camellia Sinensis leaf extract

Study type

Interventional

Funder types

Other

Identifiers

NCT05031702
0905/14122018

Details and patient eligibility

About

Camellia Sinensis leaf extract contributes to increasing energy expenditure and calorie consumption by increasing thermogenesis. The purpose of this study is to evaluate the efficacy of Camellia Sinensis on basal metabolism and body composition in overweight women or with obesity in postmenopause.

Enrollment

32 estimated patients

Sex

Female

Ages

50 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Postmenopause
  • Overweight or obesity class I-II (Body Mass Index 25-39,9 Kg/m2)

Exclusion criteria

  • Changes in heart rhythm
  • Intolerance or allergy to components
  • Obesity class III (Body Mass Index > 40 Kg/m2)

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

32 participants in 2 patient groups, including a placebo group

Dietary supplement
Active Comparator group
Description:
Extract from Camellia Sinensis leaf
Treatment:
Dietary Supplement: Camellia Sinensis leaf extract
Placebo
Placebo Comparator group
Description:
Tablets of the same size as the active component
Treatment:
Combination Product: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems